MedPath

Nova Scotia Health Authority

Nova Scotia Health Authority logo
🇨🇦Canada
Ownership
Private
Established
2014-01-01
Employees
10K
Market Cap
-
Website
http://www.nshealth.ca

Study Of the Safety of Locally Manufactured 123I-metaiodobenzylguanidine(MIBG) in Routine Clinical Use

Withdrawn
Conditions
Adrenergic Pathology
Interventions
Drug: Administration of 123Iodine MIBG
First Posted Date
2013-07-30
Last Posted Date
2022-11-14
Lead Sponsor
Nova Scotia Health Authority
Registration Number
NCT01912040
Locations
🇨🇦

Capital District Health Authority, Halifax, Nova Scotia, Canada

Digital Air Leak Monitoring for Patients Undergoing Lung Resection

Not Applicable
Completed
Conditions
Atelectasis
Pneumothorax
Interventions
Device: Dry suction pleura drainage device
Device: Digital pleural drainage system
First Posted Date
2013-03-13
Last Posted Date
2017-02-01
Lead Sponsor
Nova Scotia Health Authority
Target Recruit Count
216
Registration Number
NCT01810172
Locations
🇨🇦

Capital Health District Authority, Halifax, Nova Scotia, Canada

Validation of a Novel Dabigatran Based Peri-Operative Bridging Anticoagulation Protocol for Patients on Chronic Warfarin Therapy

Not Applicable
Withdrawn
Conditions
Venous Thromboses
Interventions
Drug: Dabigatran.
First Posted Date
2013-03-13
Last Posted Date
2017-01-31
Lead Sponsor
Nova Scotia Health Authority
Registration Number
NCT01810237

Prospective, Multi-Center Clinical Evaluation of the Open Wedge Osteotomy and Low Profile Plate & Screw (LPS) System Compared to the Proximal Chevron Osteotomy for the Treatment of Hallux Valgus With an Increased Intermetatarsal Angle

Not Applicable
Completed
Conditions
Hallux Valgus
Interventions
Procedure: proximal open wedge osteotomy with LPS system
Procedure: proximal chevron osteotomy
First Posted Date
2013-02-15
Last Posted Date
2018-07-19
Lead Sponsor
Nova Scotia Health Authority
Target Recruit Count
75
Registration Number
NCT01791634
Locations
🇨🇦

Halifax Infirmary, Halifax, Nova Scotia, Canada

Cognitive Behavioural Therapy for Social Phobia in People With Bipolar Disorder

Not Applicable
Completed
Conditions
Bipolar Disorder
Social Phobia
Interventions
Behavioral: Cognitive behavioural therapy (CBT)
First Posted Date
2012-11-29
Last Posted Date
2022-11-14
Lead Sponsor
Nova Scotia Health Authority
Target Recruit Count
9
Registration Number
NCT01736631
Locations
🇨🇦

Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada

Niapsan as Add -on Therapy to Antipsychotic Treatment in First Episode Psychosis

Phase 3
Completed
Conditions
Psychosis
Interventions
First Posted Date
2012-11-02
Last Posted Date
2015-08-07
Lead Sponsor
Nova Scotia Health Authority
Target Recruit Count
22
Registration Number
NCT01720095
Locations
🇨🇦

NS Early Psychosis Program, Halifax, Nova Scotia, Canada

A Feasibility Study of an Online Intervention for Sexual Rehabilitation in Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Behavioral: Couples Prostate Cancer Support Group
First Posted Date
2012-10-30
Last Posted Date
2024-08-21
Lead Sponsor
Nova Scotia Health Authority
Target Recruit Count
18
Registration Number
NCT01716702
Locations
🇨🇦

Capital District, Halifax, Nova Scotia, Canada

Strength Training Study for Survivors of Breast and Gynecologic Cancer

Not Applicable
Completed
Conditions
Breast Cancer
Cervical Cancer
Gynecologic Cancer
Ovarian Cancer
Uterine Cancer
Interventions
Behavioral: Strength Training
First Posted Date
2012-10-18
Last Posted Date
2015-06-08
Lead Sponsor
Nova Scotia Health Authority
Target Recruit Count
20
Registration Number
NCT01709175
Locations
🇨🇦

Exercise Lab: Queen Elizabeth II Dickson Centre, Halifax, Nova Scotia, Canada

The Laser in Pseudoexfoliation (LIP) Study

Phase 4
Withdrawn
Conditions
Glaucoma
Interventions
Procedure: SLT Laser
Drug: Prostagladin
First Posted Date
2012-10-12
Last Posted Date
2024-08-21
Lead Sponsor
Nova Scotia Health Authority
Registration Number
NCT01704989
Locations
🇨🇦

Eye Care Centre, VG Site, QEII, Halifax, Nova Scotia, Canada

AML-MDS Novel Prognostic Tests Clinical Study

Completed
Conditions
Myelodysplastic Syndrome (MDS)
Acute Myeloid Leukemia (AML)
First Posted Date
2012-09-14
Last Posted Date
2022-11-08
Lead Sponsor
Nova Scotia Health Authority
Target Recruit Count
11
Registration Number
NCT01685619
Locations
🇨🇦

Vancouver General Hospital, Vancouver, British Columbia, Canada

🇨🇦

Tom Baker Cancer Centre, Calgary, Alberta, Canada

🇨🇦

CancerCare Manitoba, Winnipeg, Manitoba, Canada

and more 3 locations
© Copyright 2025. All Rights Reserved by MedPath